Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000827871-16-000074
Filing Date
2016-08-09
Accepted
2016-08-09 16:51:28
Documents
63
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q egrx_q2x2016.htm 10-Q 888418
2 EXHIBIT 31.1 exhibit311q22016.htm EX-31.1 9699
3 EXHIBIT 31.2 exhibit312q22016.htm EX-31.2 9661
4 EXHIBIT 32.1 exhibit321q22016.htm EX-32.1 10040
  Complete submission text file 0000827871-16-000074.txt   4724204

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT egrx-20160630.xml EX-101.INS 884704
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT egrx-20160630.xsd EX-101.SCH 39109
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT egrx-20160630_cal.xml EX-101.CAL 64259
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT egrx-20160630_def.xml EX-101.DEF 173086
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT egrx-20160630_lab.xml EX-101.LAB 497750
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT egrx-20160630_pre.xml EX-101.PRE 302240
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36306 | Film No.: 161818651
SIC: 2834 Pharmaceutical Preparations